Detail

Study ID: COG ANBL1531

Title:

A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added to Intensive Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma (NBL) (IND# 134379)

Location:
Principal Investigator:
Disease:
NBL (Neuroblastoma)
Stage:
Phase III
Status:
Active - Open to Accrual